DSS, Inc. reports developments across a diversified operating platform that includes Product Packaging, Biotechnology, Commercial Lending, and Securities & Investment Management. Company updates commonly address packaging operations, financial results, balance-sheet actions, common-stock offerings, and regulatory or audit disclosures.
News also covers subsidiary activity such as Sentinel Brokers Company, Inc., a FINRA-registered broker-dealer with fixed income trading, equity market-making, and approval to act as an underwriter and selling group member for corporate securities offerings.
DSS, Inc. (NYSE American: DSS) has entered a stock purchase agreement with Alset EHome International, Inc. to issue up to 44,619,423 shares at $0.3810 each, pending shareholder approval. CEO Frank D. Heuszel described this as a strong vote of confidence that will enhance the company's balance sheet, enabling it to pursue growth opportunities across multiple sectors. COO Jason Grady emphasized the efforts to build a foundation for shareholder value creation, gearing up for the next phase of growth focused on top-line and bottom-line performance.
DSS has announced a significant acquisition by adding True Partner Capital with assets under management (AUM) of $1.7 billion into its financial services arm, DSS Securities. The acquisitions include 877 million shares from Alset EHome International in exchange for newly issued shares of DSS. Following these transactions, Alset will become the majority shareholder with a 55.52% stake. This strategic move aims to enhance growth in DSS's securities business and leverage True Partner's established platform for tailored customer solutions.
DSS, Inc. has announced its subsidiary, American Medical REIT Inc. (AMRE), acquired a 21,900 sq. ft. medical office building in Winter Haven, Florida. The primary tenant, Palm Medical Center, has a six-year lease with 1% annual rent increases. The acquisition enhances AMRE's portfolio, which now exceeds 380,000 sq. ft. of healthcare assets. Additionally, AMRE received a $4.8 million loan from American Pacific Bancorp, with detachable warrants for common stock at $10/share. This move underscores DSS's strategy in resilient medical real estate despite pandemic challenges.
Impact Biomedical, a subsidiary of DSS, has announced the development of eco-friendly bio-plastics designed to resist viruses and reduce environmental impact. Founder Daryl Thompson and his team are isolating natural compounds to enhance plastics' resistance to harmful microorganisms.
Early tests show promising anti-microbial effects against SARS-CoV-2, achieving a 90% reduction in 30 minutes and 99% in 2 hours. These bioplastics aim to address global plastic pollution and have potential applications in various sectors, with the antimicrobial market projected to reach $17.55 billion by 2026.
Value Exchange International, Inc. (OTCQB: VEII) has appointed Mr. Heng Fai Ambrose Chan to its Board of Directors as a non-executive director. Mr. Chan brings over 45 years of experience in financial restructuring and corporate transformation, having successfully restructured more than 35 companies across various sectors. Notably, five of these companies have a combined market capitalization exceeding USD 18 billion and generate over USD 1.4 billion in annual profits. This appointment is expected to enhance the company's leadership and strategic direction.
DSS, Inc. has announced the near completion of a 105,000 sq. ft. facility for its subsidiary, Premier Packaging Corporation, located in Henrietta, NY. This expansion, scheduled to start operations on February 1, 2022, more than doubles Premier's existing capacity. The investment includes approximately $12 million in CAPEX, aimed at improving production efficiency and increasing staffing by over 50%. Premier specializes in sustainable fiber-based packaging solutions, targeting a growing customer demand while minimizing environmental impacts.
DSS, Inc. (NYSE American: DSS) announced that its subsidiary, American Pacific Bancorp (APB), has issued nearly $20 million in new loans since September 2021. CEO Frank D. Heuszel highlighted the diversified loan portfolio, which includes commercial real estate financing and equipment loans. APB targets businesses with annual revenues between $5 million to over $50 million across various sectors. DSS holds over 50% of APB's shares, with plans to expand its lending network and serve clients globally, particularly in underserved markets.
DSS, Inc. (NYSE American: DSS) has opened a new office in Sacramento, California, serving as the headquarters for DSS Wealth Management and DSS AmericaFirst Quantitative Funds. This strategic move is expected to enhance sales and marketing efforts, capitalizing on strong growth potential in the wealth management sector. DSS AmericaFirst offers various mutual funds aiming to outperform benchmarks through quantitative strategies. The firm continues to diversify its portfolio to drive profitability across several high-growth sectors, including blockchain security and renewable energy.
DSS, a multinational company, announced its participation in the Emerging Growth Conference on December 8, 2021, at 2:30 p.m. ET. The event allows for real-time interaction between investors and the company's management team, including CEO Frank D. Heuszel, COO Jason Grady, and CFO Todd Macko. Attendees can ask questions following the presentation. Registration is required in advance, with a recorded version available later for those unable to attend live. DSS operates in sectors such as blockchain security, healthcare, and renewable energy.
On November 30, 2021, DSS announced the launch of DSS AmericaFirst Quantitative Funds, a suite of mutual funds managed by DSS Wealth Management. The funds include four offerings: Income Trends Fund, Defensive Growth Fund, Risk-On Risk-Off Fund, and Large Cap Buyback Fund, each aiming to outperform benchmark indices using a quantitative approach. CEO Frank D. Heuszel emphasized the growth potential and innovative strategies behind the funds. DSS Wealth Management serves as the registered investment advisor to the funds, earning fees based on average daily net assets.